dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
terbinafin orifarm 250 mg
orifarm generics (3) - terbinafinhydroklorid - tablett - 250 mg
hydroxyzine orifarm 10 mg
orifarm generics a/s - hydroksyzinhydroklorid - tablett, filmdrasjert - 10 mg
hydroxyzine orifarm 25 mg
orifarm generics a/s - hydroksyzinhydroklorid - tablett, filmdrasjert - 25 mg
ebastin orifarm 10 mg
orifarm generics a/s - ebastin - tablett, filmdrasjert - 10 mg
ebastin orifarm 20 mg
orifarm generics a/s - ebastin - tablett, filmdrasjert - 20 mg
hydrochlorothiazide orifarm 25 mg
orifarm generics (3) - hydroklortiazid - tablett - 25 mg
ganirelix orifarm 0.25 mg/0.5 ml
orifarm generics a/s - ganireliksacetat - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 0.25 mg/0.5 ml
dimethyl fumarate sandoz 240 mg
sandoz a/s - dimetylfumarat - enterokapsel, hard - 240 mg
dimethyl fumarate sandoz 120 mg
sandoz a/s - dimetylfumarat - enterokapsel, hard - 120 mg